Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ALVO is expected to report earnings to fall 73.12% to -2 cents per share on November 11
Q3'26
Est.
$-0.02
Q2'26
Missed
by $0.06
Q1'26
Missed
by $0.09
Q4'25
Beat
by $0.09
Q3'25
Beat
by $0.50
The last earnings report on August 19 showed earnings per share of -9 cents, missing the estimate of -3 cents. With 307.46K shares outstanding, the current market capitalization sits at 1.86B.